Latest News Archive
Please select Category, Year, and then Month to display items
12 January 2024
|
Story Nonsindiswe Qwabe
|
Photo Sonia Small
Since joining the UFS in 2008, Dr Grey Magaiza has worked extensively on approaches that can foster the socio-economic transformation of societies.
“The future should be one where communities can decide on their development agenda and futures. That’s the most important for me.” Dr Grey Magaiza, Deputy Director of the Centre for Gender and Africa Studies (CGAS) and Head of the Community Development programme on the Qwaqwa Campus, is passionate about capacitating communities to be agents of change and advancement. His vision for the future emphasises the empowerment of communities to take charge of their development by actively participating in decision making and the implementation of development projects that can improve their lives.
Since joining the UFS in 2008, Dr Magaiza has worked extensively on approaches that can foster the socio-economic transformation of societies. Over the years, he has crafted his research speciality into one that he is most proud of – being an interdisciplinary scientist immersed in the development of communities.
“I’m in a fortunate position of researching what I like. I say ‘fortunate’, because I’ve taken the time to understand what I’m passionate about, which is the overall field of rural livelihoods and livelihood futures – in short, community development. My research starts from an engaged university, understanding the elements that a university must use to enhance transformation and relevance to its immediate community in terms of development.”
One of the ways he has done this is by looking at social entrepreneurship as a development approach for young people in a rural setting. Through workshops with non-profit and civic organisations in Qwaqwa, Dr Magaiza has been helping these organisations to map out their needs and actively meet them through the involvement and support of external role players.
“We understand that communities are part of the national development agenda, but even that national agenda respects community knowledge and intentions and allows communities to shape their identity. A critical enabler of this is community organising. You bring back the capacity in communities to have dialogues on issues affecting them as spaces for engagement, knowledge exchange, and for people to just talk about their way forward.”
By enabling communities to define their development agenda, they can address their specific needs, challenges, and aspirations, he said. “When I look at livelihood futures, it’s quite an exciting aspect of my work – it’s like looking into a fortune tellers’ globe, because you’re not deciding for communities what they should do, but the communities themselves take those decisions.”
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004